Obtaining of the recombinant Rhil7-Cbd fusion protein

  • M. O. Usenko
  • O. B. Gorbatiuk
  • O. V. Okunev
  • D. M. Irodov
  • M. V. Koval’chuk
  • V. A. Kordium


Aim. The purpose was to obtain the recombinant fusion protein based on the human interleukin-7 (rhIL7) and cellulose binding domain (CBD). Methods. The DNA sequences encoding rhIL-7 and CBD were subcloned into the pET24a(+). Vector containing the 6His-tag sequence for further chromatographic purification of the target protein. The cells of E. coli strain BL21(DE3) were transformed with pET24-rhIL7-CBD plasmid vector. Protein synthesis was induced in clones by IPTG and by autoinduction. Results. An expression cassette of rhIL7-CBD protein has been designed. Producers of rhIL7-CBD protein were obtained. It was shown that the autoinduction protocol provides protein synthesis in E. coli (but IPTG induction doesn’t). Protein was obtained in the cytoplasmic fraction in form of inclusion bodies. In vitro method of purification of rhIL7-CBD from inclusion bodies has been worked out. Conclusions. The obtained rhIL7-CBD protein can be used for the microcrystalline cellulose immunosorbent construction for the purification of the specific polyclonal IL-7 antibodies and also for qualitative and quantitative analysis of IL-7 receptors.

Keywords: IL-7, CBD, inclusion bodies, renaturation.


Lundström W., Fewke N.M., Mackall C.L. IL-7 in human health and disease. Seminars in immunology. 2012. Vol. 24. P. 218–224. doi: 10.1016/j.smim.2012.02.005.

Gao J., Zhao L., Wan Y.Y., Zhu B. Mechanism of action of IL-7 and its potential applications and limitations in cancer immunotherapy. Int. J. Mol. Sci. 2015. Vol. 16. P. 10267–10280. doi: 10.3390/ijms160510267.

Lin J., Zhu Z., Xiao H., Wakefield M.R., Ding V.A., Bai Q., Fang Y. The role of IL-7 in Immunity and Cancer. Anticancer Research. 2017. Vol. 37. P. 963–967. doi: 10.21873/anticanres.11405.

Savino A.M., Izraeli S. Interleukin-7 signaling as a therapeutic target in acute lymphoblastic leukemia. Exp. Rev. of Hemat. 2017. Vol. 10. P. 183–185. doi: 10.1080/17474086.2017.1292121.

Mackall C.L., Fry T.J., Gress R.E. Harnessing the biology of IL-7 for therapeutic application. Nat. Rev. Immunol. 2011. Vol. 11. P. 330–342. doi: 10.1038/nri2970.

Slyvka A.V., Okunev O.V. Molecular mechanisms of versatile biological activity of interleukin-7. Biopolym. Cell. 2014. Vol. 30. P. 349–357. doi: 10.7124/bc.0008B1.

Usenko M.O., Okunev O.V., Bentsionova K.I., Gorbatiuk O.B., Irodov D.M., Kordium V.A. Obtaining of the recombinant rhIL7-BAPmut fusion protein and its functional characterization. Factors in Experimental Evolution of Organisms. 2019. Vol. 25. P. 321–326. [in Ukrainian] doi: 10.7124/FEEO.v25.1185

Morag E., Lapidot A., Govorko D., Lamed R., Wilchek M., Bayer E.A., Shoham Y. Expression, purification, and characterization of the cellulose-binding domain of the scaffoldin subunit from the cellulosome of Clostridium thermocellum. Appl. Environ. Microbiol. 1995. Vol. 61, No. 5. P. 1980–1986. doi: 10.1128/AEM.61.5.1980-1986.1995

Gilchuk P.V., Volkov G.L. Immobilization of mouse singlechain antibodies for affinity chromatography using the cellulose-binding protein. Ukr. Biokhim. Zhur. 2006. Vol. 78, No. 4. P. 160–163.

Gilchuk P.V., Okunev O.V., Pavlova M.V., Irodov D.M., Gorbatyuk O.B. Obtaining of ScFv-CBD fusion protein and its application for affinity purification of recombinant human interferon a2b. Ukr. Biochem. J. 2006. Vol. 78, No. 2. P. 52–61. [in Ukrainian]

Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: A laboratory Manual. Second edition. New York: Cold Spring Harbor Laboratory Press, 1989. 1659 p.

Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 2005. Vol. 41. P. 207–234. doi: 10.1016/j.pep.2005.01.016.

Gorbatiuk O.B., Nikolayev U.S., Irodov D.M., Dubey I.Ya., Gilchuk P.V. Refolding of ScFv-CBD fusion protein from Escherichia coli inclusion bodies. Biopolym. Cell. 2008. Vol. 24, No. 1. Р. 51–59. [in Ukrainian] doi: 10.7124/bc.000790